Saul Priceman: Phase 1 trial with PSCA-CAR T cell therapy in patients with mCRPC

Saul Priceman, Associate Professor at City of Hope, made the following post on X:

“Proud of our work published today in Nature Medicine, sharing results from our phase 1 trial with PSCA-CAR T cell therapy in patients with mCRPC. Big collaborations work Tanya Dorff, Stephen Forman, Peter Kuhn, Lior Pachter! Thank you Prostate Cancer Foundation for your support!”

Read further.
Source: Saul Priceman/X